These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 19922517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Craving and illicit heroin use among patients in heroin-assisted treatment.
    Blanken P, Hendriks VM, Koeter MW, van Ree JM, van den Brink W.
    Drug Alcohol Depend; 2012 Jan 01; 120(1-3):74-80. PubMed ID: 21782351
    [Abstract] [Full Text] [Related]

  • 4. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W, Hendriks VM, Blanken P, van Ree JM.
    Ned Tijdschr Geneeskd; 2000 Jan 15; 144(3):108-12. PubMed ID: 10674115
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U, Bonorden-Kleij K, Degkwitz P, Dilg C, Köhler WK, Passie T, Soyka M, Tanger S, Vogel M, Haasen C.
    Addiction; 2008 Jun 15; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [Abstract] [Full Text] [Related]

  • 6. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials.
    Dijkgraaf MG, van der Zanden BP, de Borgie CA, Blanken P, van Ree JM, van den Brink W.
    BMJ; 2005 Jun 04; 330(7503):1297. PubMed ID: 15933353
    [Abstract] [Full Text] [Related]

  • 7. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
    Schäfer I, Eiroa-Orosa FJ, Verthein U, Dilg C, Haasen C, Reimer J.
    Psychopathology; 2010 Jun 04; 43(2):88-95. PubMed ID: 20068379
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment.
    van der Zanden BP, Dijkgraaf MG, Blanken P, van Ree JM, van den Brink W.
    Drug Alcohol Depend; 2007 Jan 05; 86(1):84-90. PubMed ID: 16806740
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program.
    Maremmani I, Pani PP, Mellini A, Pacini M, Marini G, Lovrecic M, Perugi G, Shinderman M.
    J Addict Dis; 2007 Jan 05; 26(1):61-70. PubMed ID: 17439869
    [Abstract] [Full Text] [Related]

  • 13. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT, Tait RJ, Hulse GK.
    Arch Gen Psychiatry; 2008 Apr 05; 65(4):457-65. PubMed ID: 18391134
    [Abstract] [Full Text] [Related]

  • 14. The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service.
    Oliver P, Keen J, Rowse G, Ewins E, Griffiths L, Mathers N.
    Addiction; 2010 Apr 05; 105(4):732-9. PubMed ID: 20403022
    [Abstract] [Full Text] [Related]

  • 15. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials.
    van den Brink W, Hendriks VM, Blanken P, Koeter MW, van Zwieten BJ, van Ree JM.
    BMJ; 2003 Aug 09; 327(7410):310. PubMed ID: 12907482
    [Abstract] [Full Text] [Related]

  • 16. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.
    J Psychiatr Pract; 2009 May 09; 15(3):227-34. PubMed ID: 19461397
    [Abstract] [Full Text] [Related]

  • 17. Heroin-assisted treatment in the Netherlands: History, findings, and international context.
    Blanken P, van den Brink W, Hendriks VM, Huijsman IA, Klous MG, Rook EJ, Wakelin JS, Barendrecht C, Beijnen JH, van Ree JM.
    Eur Neuropsychopharmacol; 2010 Apr 09; 20 Suppl 2():S105-58. PubMed ID: 20362236
    [Abstract] [Full Text] [Related]

  • 18. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N, Groshkova T, Hellier J, Charles V, Martin A, Forzisi L, Lintzeris N, Zador D, Williams H, Carnwath T, Mayet S, Strang J.
    Addiction; 2015 Mar 09; 110(3):479-90. PubMed ID: 25251885
    [Abstract] [Full Text] [Related]

  • 19. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P, Guglielmino L, Marzorati P, Silenzio R, De Chiara M, Corrado F, Cocchi L, Cozzolino E.
    J Subst Abuse Treat; 2006 Jul 09; 31(1):3-7. PubMed ID: 16814005
    [Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ.
    Arch Gen Psychiatry; 2006 Jan 09; 63(1):102-9. PubMed ID: 16389204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.